AtriCure Inc reports results for the quarter ended in September - Earnings Summary

AtriCure

01/11/2023 21:02

* AtriCure Inc  ATRC.OQ  reported a quarterly adjusted loss
of 20
cents​​ per share for the quarter ended in September, higher
than the same quarter last year, when the company reported EPS
of -27 cents.  The mean expectation of nine analysts for the
quarter was for a loss of 31 cents per share. Wall Street
expected results to range from -34 cents to -26 cents per share.
    * Revenue rose 18.1% to $98.29 million from a year ago;
analysts
expected $96.65 million. 
    * AtriCure Inc's reported EPS for the quarter was a loss
of 20
cents​.
    * The company reported a quarterly loss of $9.06 million.
    * AtriCure Inc shares had fallen by 20.9% this quarter and
lost 21.9% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 2.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for AtriCure Inc is
$65.00 
This summary was machine generated from LSEG data November 1 at
09:02 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2023      -0.31          -0.20          Beat
 Jun. 30 2023      -0.30          -0.11          Beat
 Mar. 31 2023      -0.34          -0.23          Beat
 Dec. 31 2022      -0.18          -0.09          Beat